Cargando…
Author Correction: ROR1 is upregulated in endometrial cancer and represents a novel therapeutic target
Autores principales: | Liu, Dongli, Gunther, Kate, Enriquez, Luis A., Daniels, Benjamin, O’Mara, Tracy A., Tang, Katrina, Spurdle, Amanda B., Ford, Caroline E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240005/ https://www.ncbi.nlm.nih.gov/pubmed/35764678 http://dx.doi.org/10.1038/s41598-022-15043-7 |
Ejemplares similares
-
ROR1 is upregulated in endometrial cancer and represents a novel therapeutic target
por: Liu, Dongli, et al.
Publicado: (2020) -
ROR2 Is Epigenetically Regulated in Endometrial Cancer
por: Liu, Dongli, et al.
Publicado: (2021) -
ROR1 and ROR2 expression in pancreatic cancer
por: Liu, Dongli, et al.
Publicado: (2021) -
Meta-analysis of gene expression studies in endometrial cancer identifies gene expression profiles associated with aggressive disease and patient outcome
por: O’Mara, Tracy A., et al.
Publicado: (2016) -
Analysis of Promoter-Associated Chromatin Interactions Reveals Biologically Relevant Candidate Target Genes at Endometrial Cancer Risk Loci
por: O’Mara, Tracy A., et al.
Publicado: (2019)